United States

IVERIC bio is a biopharmaceutical company that focuses on developing treatments for retinal diseases, particularly age-related and orphan inherited retinal diseases. The company has several drugs in various stages of clinical trials, including Zimura for the treatment of geographic atrophy secondary to dry age-related macular degeneration, and STAR or OPH2005 for the treatment of leber congenital amaurosis type 10 and autosomal recessive stargardt disease. The company also has several discovery and research programs for various retinal diseases.

Google

Gerente de Producto

Científico de Datos

Iveric Bio

Iveric Bio Empleos Disponibles

¿Estás listo para hacer crecer tu carrera? Revisa estas posiciones abiertas en Iveric Bio.